Zusammenfassung
In der Entstehung und Aufrechterhaltung von autoimmunen rheumatologischen Erkrankungen spielen CD4-T-Zellen eine wesentliche Rolle. Die kürzliche Entdeckung von Interleukin- (IL-)17-produzierenden Th17-Zellen als potente proinflammatorische T-Zell-Population erweitert das Verständnis pathophysiologischer Vorgänge, die zuvor nicht durch die Th1/Th2-Dichotomie erklärt werden konnten. Die in diesem Artikel diskutierten aktuellen Daten aus humanen Studien deuten auf eine wichtige pathogenetische Funktion von Th17-Zellen und dem von ihnen produzierten IL-17 bei zahlreichen rheumatologischen Erkrankungen hin, sodass auf Th17-Zellen/IL-17-zielende Therapien von potenziellem Nutzen in der Behandlung dieser Erkrankungen sein könnten.
Abstract
CD4 T cells play a major role in the development and persistence of autoimmune rheumatic diseases. The recent identification of IL-17-producing Th17 cells as a potent proinflammatory subset extends the understanding of pathophysiological processes not explained by the Th1/Th2 dichotomy. The recent data from human studies discussed in this article indicate an important pathogenic function for Th17 cells and Th17-derived IL-17 suggesting that therapies targeting Th17 cells/IL-17 may be of potential use in the treatment of those diseases.
Literatur
Agarwal S, Misra R, Aggarwal A (2008) Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 35:515–519
Cai L, Yin J, Starovasnik M et al (2001) Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine 16:10–21
Chabaud M, Durand J, Buchs N et al (1999) Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970
Chabaud M, Lubberts E, Joosten L et al (2001) IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res Ther 3:168–177
Codolo G, Amedei A, Steere A et al (2008) Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum 58:3609–3617
Infante-Duarte C, Horton H, Byrne M et al (2000) Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 165:6107–6115
Jandus C, Bioley G, Rivals J et al (2008) Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 58:2307–2317
Kirkham B, Lassere M, Edmonds J et al (2006) Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 54:1122–1131
Kohno M, Tsutsumi A, Matsui H et al (2008) Interleukin-17 gene expression in patients with rheumatoid arthritis. Mod Rheumatol 18:15–22
Kotake S, Udagawa N, Takahashi N et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352
Kurasawa K, Hirose K, Sano H et al (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455–2463
Leipe S, Skapenko A, Schulze-Koops H (2008) Increased Th17 cell frequency and effector functions in patients with early rheumatoid and psoriatic arthritis. Arthritis Rheum 58 (Suppl):1253–1254
Lubberts E (2008) IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 41:84–91
Raza K, Falciani F, Curnow S et al (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7:R784–795
Singh R, Aggarwal A, Misra R (2007) Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J Rheumatol 34:2285–2290
Tesmer L, Lundy S, Sarkar S et al (2008) Th17 cells in human disease. Immunol Rev 223:87–113
Wendling D, Cedoz J, Racadot E et al (2007) Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 74:304–305
Wong C, Lit L, Tam L et al (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127:385–393
Yamada H, Nakashima Y, Okazaki K et al (2008) Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann Rheum Dis 67:1299–1304
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leipe, J., Skapenko, A. & Schulze-Koops, H. Th17-Zellen – eine neue proinflammatorische T-Zell-Population und ihre Bedeutung für rheumatologische Autoimmunerkrankungen. Z. Rheumatol. 68, 405–408 (2009). https://doi.org/10.1007/s00393-009-0473-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-009-0473-z